Sep 23, 2017

Starpharma rockets on cancer drug hope

Starpharma rockets on cancer drug hope

The Herald Sun noted strong investor interest and support for Starpharma regarding its positive phase 1 DEP® docetaxel trial and that no neutropenia was reported in any patients.

Go to article